Aurobindo Pharma has paid $139.2 million (over Rs 600 crore) for the redemption of outstanding overseas bonds issued in 2006.
With the latest payout, the company has now paid an aggregate $203.86 million for the redemption of two tranches of foreign currency convertible bonds (FCCBs) issued in May 2006, Aurobindo Pharma said in a filing to the Bombay Stock Exchange today.
“Pursuant to this, all bonds issued by the company in May 2006, have been extinguished in full and there are no outstanding as on date,” it added.
After the repurchase and cancellation of FCCBs from time-to-time, the outstanding nominal value of FCCBs of $106.25 million has been paid in full at the redemption price of 146.285 per cent of the principal amount on the maturity date, it said.
The company had issued FCCBs aggregating $150 million in one tranche, dubbed Tranche A, on May 12, 2006.
The company has also paid $32.95 million for the redemption of FCCBs issued on May 17, 2006. The Hyderabad-based firm had issued FCCBs aggregating $50 million in this second tranche, Tranche B.
“... The outstanding nominal value of FCCBs of $32.95 million has been paid in full at the redemption price of 146.991 per cent of its principal amount on maturity date, May 17, 2011,” the company said.
Meanwhile, the shares of Aurobindo Pharma were being quoted at Rs 192.50 apiece on the BSE in the late afternoon trade today, up 1.5 per cent from the previous close.